Clinical Trials Logo

Clinical Trial Summary

Two percent of all patients presenting to the Emergency Departments have complaints involving the eye. Corneal abrasions are a common diagnosis with patients with eye pain and often cause significant discomfort. Current treatment includes a thorough evaluation of the eye followed by patching, empiric antibiotics, cycloplegics and oral pain medicines. This study will be a randomized controlled trial to determine the safety and efficacy of BCLs. It will involve the initial patient evaluation followed by a return visit to the Emergency Department within 36 hours for re-examination. At each visit, the patient will be assessed for the size and location of the abrasion along with their report of pain using a visual analog scale. Data will be recorded on a standard data collection sheet. Telephone contact will be made at 30 days to ensure resolution of abrasion and that no complications ensued.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03206723
Study type Interventional
Source Los Angeles Biomedical Research Institute
Contact David Tanen, MD
Phone 3102223501
Email dtanen@labiomed.org
Status Recruiting
Phase Phase 2
Start date July 1, 2017
Completion date March 1, 2019

See also
  Status Clinical Trial Phase
Terminated NCT04159714 - Bandage Contact Lens Application for the Management of Corneal Abrasion N/A
Withdrawn NCT02483897 - Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion Phase 3
Completed NCT04187417 - Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions N/A
Not yet recruiting NCT05534217 - The Debridement To Treat The Traumatic Corneal Abrasion N/A